{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:27:53Z","timestamp":1794436073592,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.expneurol.2026.115759","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:07:38Z","timestamp":1775315258000},"page":"115759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A refined chronic MPTP\/probenecid model of Parkinson's disease in mature adult mice"],"prefix":"10.1016","volume":"402","author":[{"given":"Zhiqiang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Mellick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115759_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jnc.12343","article-title":"Probenecid potentiates MPTP\/MPP+ toxicity by interference with cellular energy metabolism","volume":"127","author":"Alvarez-Fischer","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.115759_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2020.08.017","article-title":"Transgenerational transduction of MPTP-induced alterations in a Parkinson\u2019s disease mouse model","volume":"79","author":"Alvarez-Fischer","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2026.115759_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2011.09.026","article-title":"Age- and duration-dependent effects of MPTP on cortical serotonin systems","volume":"504","author":"Ansah","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.115759_bb0020","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1111\/febs.12335","article-title":"The hallmarks of Parkinson's disease","volume":"280","author":"Antony","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2026.115759_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.115759_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0077579","article-title":"Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat","volume":"93","author":"Barnes","year":"1979","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0035","first-page":"507","article-title":"Receptor subtype-specific dopaminergic agents and unconditioned behavior","volume":"43","author":"Beninger","year":"1991","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.expneurol.2026.115759_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson\u2019s disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson\u2019s disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0055","article-title":"Predictors of cognitive impairment in newly diagnosed Parkinson\u2019s disease with normal cognition at baseline: a 5-year cohort study","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2018.07.011","article-title":"1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine\/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson\u2019s disease in mice","volume":"392","author":"Choi","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0065","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1007\/s12035-016-0147-1","article-title":"MPP+-lesioned mice: an experimental model of motor, emotional, memory\/learning, and striatal neurochemical dysfunctions","volume":"54","author":"Cunha","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00031305.1990.10475751","article-title":"A suggestion for using powerful and informative tests of normality","volume":"44","author":"Dagostino","year":"1990","journal-title":"Am. Stat."},{"key":"10.1016\/j.expneurol.2026.115759_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-8993(90)90088-S","article-title":"Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis","volume":"519","author":"Date","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2026.115759_bb0080","first-page":"e2609","article-title":"Measuring motor coordination in mice","volume":"75","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2026.115759_bb0085","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","article-title":"Procedures for detecting outlying observations in samples","volume":"11","author":"Grubbs","year":"1969","journal-title":"Technometrics"},{"key":"10.1016\/j.expneurol.2026.115759_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12565-018-0457-7","article-title":"Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson\u2019s disease model of mice","volume":"94","author":"Haeri","year":"2019","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.expneurol.2026.115759_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tox.2007.11.018","article-title":"The role of dopamine transporter in selective toxicity of manganese and rotenone","volume":"244","author":"Hirata","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.expneurol.2026.115759_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/NDT.S235562","article-title":"Phosphorylation of tau and \u03b1-synuclein induced neurodegeneration in MPTP mouse model of parkinson\u2019s disease","volume":"16","author":"Hu","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.expneurol.2026.115759_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson's disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2026.115759_bb0135","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/nprot.2007.367","article-title":"Analyzing grooming microstructure in neurobehavioral experiments","volume":"2","author":"Kalueff","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2026.115759_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/syn.890150107","article-title":"Dopamine transporter mutants selectively enhance MPP+ transport","volume":"15","author":"Kitayama","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2026.115759_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbr.2016.02.040","article-title":"Physical exercise counteracts MPTP-induced changes in neural precursor cell proliferation in the hippocampus and restores spatial learning but not memory performance in the water maze","volume":"307","author":"Klein","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2026.115759_bb0160","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115759_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.physbeh.2014.05.006","article-title":"Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure","volume":"133","author":"Kulesskaya","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2026.115759_bb0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","article-title":"Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents","volume":"114","author":"Lin","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.115759_bb0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson\u2019s disease: recent advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.expneurol.2026.115759_bb0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease","volume":"98","author":"Luchtman","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2026.115759_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1474-4422(16)30329-5","article-title":"Cognitive impairment in Parkinson's disease","volume":"16","author":"Majbour","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.115759_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-008-0350-x","article-title":"Animal models of Parkinson's disease progression","volume":"115","author":"Meredith","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2026.115759_bb0210","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2026.115759_bb0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.expneurol.2026.115759_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13409","article-title":"Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice","volume":"136","author":"Munoz-Manchado","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.115759_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105579","article-title":"In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity","volume":"162","author":"Novello","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115759_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2006.03.017","article-title":"Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL\/6 mice","volume":"401","author":"Ohashi","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.115759_bb0235","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.115759_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.expneurol.2026.115759_bb0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","article-title":"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson\u2019s disease","volume":"17","author":"Prediger","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.expneurol.2026.115759_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson\u2019s disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2026.115759_bb0260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson\u2019s disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.expneurol.2026.115759_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114730","article-title":"Barnes maze test for spatial memory: a new, sensitive scoring system for mouse search strategies","volume":"458","author":"Rodriguez Peris","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2026.115759_bb0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","article-title":"Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice","volume":"14","author":"Rousselet","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115759_bb0275","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2026.115759_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"key":"10.1016\/j.expneurol.2026.115759_bb0285","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00702-004-0203-2","article-title":"Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration","volume":"111","author":"Storch","year":"2004","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.expneurol.2026.115759_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10253890.2018.1438405","article-title":"Exploratory rearing: a context- and stress-sensitive behavior recorded in the open-field test","volume":"21","author":"Sturman","year":"2018","journal-title":"Stress"},{"key":"10.1016\/j.expneurol.2026.115759_bb0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2020.09.057","article-title":"Nogo-A\/S1PR2 signaling pathway inactivation decreases microvascular damage and enhances microvascular regeneration in PDMCI mice","volume":"449","author":"Tang","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.115759_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114704","article-title":"Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson\u2019s disease","volume":"374","author":"Tassan Mazzocco","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0305","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/13803390590954236","article-title":"Memory deficits in Parkinson\u2019s disease","volume":"28","author":"Whittington","year":"2006","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.expneurol.2026.115759_bb0310","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3988","article-title":"Transcardiac perfusion of the mouse for brain tissue dissection and fixation","volume":"11","author":"Wu","year":"2021","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.expneurol.2026.115759_bb0315","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11064-007-9533-4","article-title":"Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein","volume":"33","author":"Yu","year":"2008","journal-title":"Neurochem. Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:57:52Z","timestamp":1794434272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S0014488626001226"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115759","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A refined chronic MPTP\/probenecid model of Parkinson's disease in mature adult mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115759"}}